ANAB News - Candlesense

Anaptys Announces Participation in September Investor Conferences

SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that...

Investor

4 days ago

Anaptys Announces Second Quarter 2025 Financial Results and Provides Business Update

SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported finan...

Are there any upcoming catalysts (e.g., data readouts, conference presentations) that could move the share price? What are the risks highlighted in the management discussion that could affect future performance? How does the updated net cash position affect the potential for future M&A activity?

Earnings

25 days ago